A detailed history of Bank Of America Corp transactions in Rezolute, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 362,259 shares of RZLT stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
362,259
Previous 274,916 31.77%
Holding current value
$1.78 Million
Previous $1.18 Million 48.56%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.13 - $5.31 $360,726 - $463,791
87,343 Added 31.77%
362,259 $1.76 Million
Q2 2024

Aug 14, 2024

BUY
$2.29 - $5.79 $629,557 - $1.59 Million
274,916 New
274,916 $1.18 Million
Q4 2023

Feb 14, 2024

BUY
$0.74 - $1.24 $29 - $49
40 New
40 $0
Q4 2022

Feb 10, 2023

BUY
$1.38 - $2.84 $102 - $210
74 New
74 $0

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $191M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.